Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rossi

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic LeukemiaRiccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia|August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Frontiers in Immunology|September 29, 2025
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritisSimeone Andrulli, Lucio Manenti, Francesco Reggiani, et al.
Leukemia|June 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemiaFilippo Vit, Tamara Bittolo, Antonella Zucchetto, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
JAMA Network Open|April 9, 2024
Diagnostic Delay of Celiac Disease in ChildhoodPaola Ilaria Bianchi, Marco Vincenzo Lenti, Clarissa Petrucci, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World StudyDaria Maniero, Matteo Ghisa, Alessandro Bruschi, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic LeukemiaRiccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia|August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligandsErika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Frontiers in Immunology|September 29, 2025
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritisSimeone Andrulli, Lucio Manenti, Francesco Reggiani, et al.
Leukemia|June 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemiaFilippo Vit, Tamara Bittolo, Antonella Zucchetto, et al.
International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.
JAMA Network Open|April 9, 2024
Diagnostic Delay of Celiac Disease in ChildhoodPaola Ilaria Bianchi, Marco Vincenzo Lenti, Clarissa Petrucci, et al.
Pageof 20